Medicinal Chemistry Journal of Medicinal Chemistry (ACS)
Swapping tert-butyl for gem-dimethylcarbinol to cut lipophilicity
- A perspective-style case for swapping tert-butyl for gem-dimethylcarbinol, which keeps similar bulk but is far less greasy than most tert-butyl mimics.
- It may help balance solubility, permeability and metabolic clearance in multi-parameter optimization.
- The main drawback is higher efflux, a poor fit for CNS programs unless the structure is tuned.
- The group is stable, not a flagged toxicophore, easy to install, and present in some approved drugs.
Before committing, I'd want matched pairs against the oxetane and CF3-cyclopropyl swaps. The new hydroxyl adds a hydrogen-bond donor, so a buried, greasy pocket may charge a desolvation penalty that eats the potency gain. The efflux liability is the same donor at work, so check permeability early.
Paper: Journal of Medicinal Chemistry (ACS) ↗ gem-Dimethylcarbinol: A tert-Butyl Bioisostere with Greatly Reduced Lipophilicity